Core Points - The company held its first extraordinary general meeting of shareholders in 2025 on September 15, 2025, with no proposals for increase, change, or rejection [1][3] - The meeting was conducted both in-person and via online voting, ensuring compliance with relevant laws and regulations [2][4] Meeting Details - The meeting was convened by the company's board of directors and was presided over by Director Zhou Jinfeng [3][6] - The in-person meeting took place at 14:00 on September 15, 2025, at a specified location in Shenyang, with online voting available throughout the day [5][6] - A total of 55 shareholders participated, representing 73,359,851 shares, which is 47.2364% of the total voting shares [8] Voting Results - The following proposals were approved during the meeting: - The proposal to reappoint the auditing firm for the 2025 fiscal year received 99.7930% approval [11] - The proposal to amend the company's articles of association was approved with 99.7924% [13] - Various governance rules were revised and approved, including the rules for shareholder meetings and board meetings, with approval rates exceeding 99.79% [16][20][23] - The proposal to use part of the raised funds to acquire 70.65% of the shares of a subsidiary was approved with 99.8024% [30] Legal Opinions - The meeting was witnessed by lawyers from a reputable law firm, confirming that the procedures followed were in accordance with legal requirements [32] Additional Announcements - The company announced the resignation of non-independent director Li Pingping and the election of Li Lijuan as a representative director from the employees [36][37]
辽宁何氏眼科医院集团股份有限公司 2025年第一次临时股东大会决议公告